CDKN2B-AS1 and neoplasm: This enhanced NF-κB pathway activation may also contribute to a degree of chemosensitivity in these tumor cells, as levels of ANRIL expression have been found to correlate with tumors’ sensitivity to chemotherapeutic treatment(Zhou et al. 2021).